Skip to main content
Year archive

INVEX THERAPEUTICS LTD — 2023 filings

All 51 regulatory filings released by INVEX THERAPEUTICS LTD (IXC) in 2023, sourced directly from the official regulator.

51 Filings
2023 Period
2023 filings (51)
Filing Released Lang
Notification of cessation of securities - IXC 4 pages 23.8KB
Regulatory Filings
2023-12-28 English
Invex and Peptron Mutually Terminate Manufacturing Agreement 2 pages 189.0KB
Regulatory Filings
2023-12-21 English
Results of Meeting 2 pages 213.1KB
Regulatory Filings
2023-12-04 English
Effective Date of Capital Return 2 pages 194.1KB
Regulatory Filings
2023-12-04 English
Payment of Capital Return Proceeds 3 pages 402.1KB
Regulatory Filings
2023-11-29 English
Change in substantial holding 2 pages 197.4KB
Regulatory Filings
2023-11-27 English
Chair's Address to Shareholders 5 pages 230.4KB
Regulatory Filings
2023-11-27 English
Results of Meeting 2 pages 209.4KB
Regulatory Filings
2023-11-27 English
Change of Director's Interest Notice x 3 6 pages 333.1KB
Regulatory Filings
2023-11-26 English
Invex Granted European Patent for Exenatide in Hydrocephalus 2 pages 219.3KB
Regulatory Filings
2023-11-21 English
Notification of cessation of securities - IXC 4 pages 23.7KB
Regulatory Filings
2023-11-21 English
Notification of cessation of securities - IXC 4 pages 23.8KB
Regulatory Filings
2023-11-19 English
Notification of cessation of securities - IXC 4 pages 23.9KB
Regulatory Filings
2023-11-09 English
Notification of cessation of securities - IXC 4 pages 23.7KB
Regulatory Filings
2023-11-09 English
Initial Director's Interest Notice 2 pages 240.2KB
Regulatory Filings
2023-11-08 English
Change in substantial holding 2 pages 197.5KB
Regulatory Filings
2023-11-07 English
Appointment of Non-executive Director 2 pages 190.6KB
Regulatory Filings
2023-11-07 English
Notice of General Meeting/Proxy Form 14 pages 1.5MB
Regulatory Filings
2023-11-01 English
Proposed Capital Return to Shareholders of $14.0 Million 2 pages 199.6KB
Regulatory Filings
2023-10-31 English
Return of Capital - IXC 4 pages 24.9KB
Regulatory Filings
2023-10-31 English
Notification of cessation of securities - IXC 4 pages 23.8KB
Regulatory Filings
2023-10-19 English
Notice of Annual General Meeting/Proxy Form 18 pages 1.6MB
Regulatory Filings
2023-10-18 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 534.7KB
Regulatory Filings
2023-10-11 English
Change in substantial holding 2 pages 197.4KB
Regulatory Filings
2023-09-27 English
Date of AGM and Closing Date for Director Nominations 1
Regulatory Filings
2023-09-24 English
Becoming a substantial holder 2 pages 147.8KB
Regulatory Filings
2023-08-30 English
Change of Director's Interest Notice 2 pages 270.2KB
Regulatory Filings
2023-08-24 English
Invex issued US patent for Traumatic Brain Injury 2 pages 217.8KB
Regulatory Filings
2023-08-22 English
Invex to close IIH Evolve Phase III Clinical Trial 4 pages 241.4KB
Regulatory Filings
2023-08-20 English
Trading Halt 2 pages 232.6KB
Regulatory Filings
2023-08-17 English
Appendix 4E and Annual Report to shareholders 54 pages 1.7MB
Regulatory Filings
2023-08-16 English
Appendix 4G 13 pages 387.0KB
Regulatory Filings
2023-08-16 English
Corporate Governance Statement 2023 16 pages 474.4KB
Regulatory Filings
2023-08-16 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 526.6KB
Regulatory Filings
2023-07-09 English
Final Director's Interest Notice 2 pages 261.5KB
Regulatory Filings
2023-07-09 English
Final Director's Interest Notice (AS) 2 pages 262.7KB
Regulatory Filings
2023-07-09 English
Director Resignations and Appointment of Non-Executive Chair 2 pages 193.7KB
Regulatory Filings
2023-07-02 English
Phase III Clinical Trial Update and New IIH Market Analysis 6 pages 317.3KB
Regulatory Filings
2023-06-27 English
Invex Granted European Orphan Drug Designation for TBI 2 pages 201.7KB
Regulatory Filings
2023-06-22 English
Invex Receives Regulatory Approval for IIH EVOLVE in France 2 pages 197.7KB
Regulatory Filings
2023-04-20 English
Israel Ministry of Health Approval for IIH EVOLVE 3 pages 197.4KB
Regulatory Filings
2023-04-19 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 440.1KB
Regulatory Filings
2023-04-19 English
March Appendix 4C and Investor Conference Call Details 2 pages 191.2KB
Regulatory Filings
2023-04-16 English
Notification of cessation of securities - IXC 4 pages 24.2KB
Regulatory Filings
2023-04-11 English
German Approval for IIH EVOLVE Phase 3 Clinical Trial 2 pages 196.1KB
Regulatory Filings
2023-03-19 English
Publication of Invex IIH Phase II Pressure Trial Results 2 pages 227.1KB
Regulatory Filings
2023-03-13 English
Half Year Accounts 20 pages 425.4KB
Regulatory Filings
2023-02-16 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 463.6KB
Regulatory Filings
2023-01-24 English
Notification of cessation of securities - IXC 4 pages 24.2KB
Regulatory Filings
2023-01-22 English
First US Clinical Site Activated in IIH EVOLVE Phase III 3 pages 199.9KB
Regulatory Filings
2023-01-18 English
Notice of Quarterly Investor Call 2 pages 192.9KB
Regulatory Filings
2023-01-18 English